Session 4: The Future of CHILD: What’s next?

As the CHILD Study follows its young subjects at age 8 and beyond, lead investigators will discuss new areas of research within the Study, and the Study’s increasing relevance to our broader understanding of the Developmental Origins of Health and Disease (DOHaD).

Session moderator: Dr. Padmaja Subbarao

DOHAD and cardiometabolic outcomes

Speaker: Dr. Sonia Anand

Dr. Anand will discuss how the CHILD Study, although designed as an asthma and allergy birth cohort, is generating data that can be used to answer broader questions about the Developmental Origins of Health and Disease (DOHaD), including cardiometabolic disease, and why this is important.

Trajectories toward anxiety and depression

Speaker: Dr. Peter Szatmari

Rates of anxiety and depression are much higher in those with chronic disease. Dr. Szatmari will discuss how future research plans of CHILD might help shed light on these common origins.